{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:23:26Z","timestamp":1781846606338,"version":"3.54.5"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.htct.2024.06.002","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T10:24:48Z","timestamp":1724408688000},"page":"S202-S207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S6","title":["Comparison of plasma cell bone marrow counts by different methods in patients diagnosed with plasma cell disorders"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1304-1846","authenticated-orcid":false,"given":"Claudia","family":"Monteiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo","family":"Campregher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Pasqualin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nydia","family":"Bacal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6943-5158","authenticated-orcid":false,"given":"Liliana","family":"Suganuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Velloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.htct.2024.06.002_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.pop.2016.07.002","article-title":"Plasma cell disorders","volume":"43","author":"Castillo","year":"2016","journal-title":"Primary Care"},{"issue":"8","key":"10.1016\/j.htct.2024.06.002_bib0002","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am J Hematol"},{"issue":"10272","key":"10.1016\/j.htct.2024.06.002_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"van de Donk","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.htct.2024.06.002_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2020.11.014","article-title":"Multiple myeloma: EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020","volume":"32","author":"Dimopoulos","year":"2021","journal-title":"Ann Oncol: Official J Eur Soc Med Oncol"},{"issue":"12","key":"10.1016\/j.htct.2024.06.002_bib0005","article-title":"Multiple Myeloma, Version 3.2021, NCCN clinical practice guidelines in oncology","volume":"18","author":"Kumar","year":"2020","journal-title":"J Nat Comprehens Cancer Network: JNCCN"},{"issue":"3","key":"10.1016\/j.htct.2024.06.002_bib0006","doi-asserted-by":"crossref","DOI":"10.4081\/hr.2011.e22","article-title":"Comparison of bone marrow aspirate cytology, touch imprint cytology and trephine biopsy for bone marrow evaluation","volume":"3","author":"Chandra","year":"2011","journal-title":"Hematol Rep"},{"issue":"3","key":"10.1016\/j.htct.2024.06.002_bib0007","article-title":"Comparison of bone marrow aspiration cytology with bone marrow trephine biopsy histopathology: an observational study","volume":"9","author":"Gilotra","year":"2017","journal-title":"J Lab Physicians"},{"issue":"11","key":"10.1016\/j.htct.2024.06.002_bib0008","article-title":"Value of bone marrow imprint smears in early diagnosis of bone marrow pathologies","volume":"8","author":"Tilak","year":"2014","journal-title":"J Clin Diagnostic Res: JCDR"},{"issue":"1","key":"10.1016\/j.htct.2024.06.002_bib0009","article-title":"Role of flow cytometry in the diagnosis and prognosis of plasma cell myeloma","volume":"9","author":"H","year":"2016","journal-title":"Surg Pathol Clin"},{"issue":"5","key":"10.1016\/j.htct.2024.06.002_bib0010","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.13807","article-title":"A systematic study comparing aspirate versus trephine for quantifying plasma cell infiltration in newly-diagnosed myeloma","volume":"174","author":"Gabriel","year":"2016","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.htct.2024.06.002_bib0011","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2141.1992.tb04592.x","article-title":"Comparison of plasma cell infiltration in bone marrow biopsies and aspirates in patients with multiple myeloma","volume":"82","author":"Terpstra","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1016\/j.htct.2024.06.002_bib0012","doi-asserted-by":"crossref","DOI":"10.1186\/1746-1596-5-30","article-title":"Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma","volume":"5","author":"Stifter","year":"2010","journal-title":"Diagn Pathol"},{"issue":"2","key":"10.1016\/j.htct.2024.06.002_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/jcp.2007.049130","article-title":"Bone marrow trephine combined with immunohistochemistry is superior to bone marrow aspirate in follow-up of myeloma patients","volume":"61","author":"Joshi","year":"2008","journal-title":"J Clin Pathol"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S253113792400302X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S253113792400302X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T11:02:34Z","timestamp":1737975754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S253113792400302X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":13,"alternative-id":["S253113792400302X"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2024.06.002","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of plasma cell bone marrow counts by different methods in patients diagnosed with plasma cell disorders","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2024.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}